Elagolix-d 9

Overview

Elagolix-d 9 is the deuterium labeled Elagolix. Elagolix sodium is a highly effective, selective, oral-active, short-term, non-peptide gonadotropin-releasing hormone receptor ( GnRH receptor ) antagonist (K D = 54 pM) and NFAT inhibitor, which can be used to study pain related to endometriosis. .

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Isotope-Labeled Compounds | Products > Signaling Pathways > GnRH Receptor | Products > Signaling Pathways > Nuclear Factor of activated T Cells (NFAT)

Product Information

• Catalog No.: HY-115633S
• CAS No.: 2455524-81-7
• Molecular Formula: C32H21D9F5N3O5
• Molecular Weight: 640.65
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source